Thomas Willshare

Co-founder and Non-Executive Director at Rapid Fluidics

Thomas Willshare has a diverse work experience spanning multiple industries and roles. Starting from 2006, they worked as a Graduate Engineer at Contract Design (Northern) for one year. Thomas then moved on to work as a Mechanical Engineer at D3-UK Ltd from August 2007 to September 2008. In September 2008, they joined Procter & Gamble as a Design Engineer, where they developed 3D CAD models and designed modification parts for high-speed packaging equipment. Thomas worked there until March 2011.

Thomas then joined National Oilwell Varco, where they held various roles. Thomas started as a Design Engineer, working on a range of oil and gas products. Thomas then moved on to become a Lead Design Engineer, managing multiple projects and leading an engineering functional design team. Eventually, they became the New Product Development Manager responsible for coordinating global new product development within the Pressure Performance Systems (PPS) division. Thomas worked at National Oilwell Varco from March 2011 to December 2016.

In December 2016, Thomas joined QuantuMDx Group Limited as the System Technical Lead. Thomas led instrument and disposable activities across research and development, working on the design, development, and commercialization of a portable molecular diagnostic device. Thomas held this position until August 2019.

From May 2019 to the present, Thomas has been serving as the Chief Technology Officer / Director at Fewer Moving Parts, a Systems Engineering consultancy. This role involves helping inventors and innovators in the Scientific, Consumer Goods, and Energy industries bring their ideas to life and take functional prototypes to market.

In July 2020, Thomas co-founded Rapid Fluidics and serves as a Non-Executive Director.

Finally, since May 2021, Thomas has been the Vice President of Product Development at miDiagnostics. Thomas initially served as a Consultant System Architect, working on the development and commercialization of miDiagnostics' Complete Blood Count (CBC) product. Currently, they lead the product development activities, focusing on an ultra-fast Point of Care PCR platform based on unique silicon chip technology.

Overall, Thomas Willshare has extensive experience in product development, system architecture, and engineering, with a specialization in the medical diagnostics and oil and gas industries.

Thomas Willshare completed their undergraduate education from 2002 to 2006 at Newcastle University, where they earned a degree in Mechanical and Design Engineering (M.Eng). In 2013 to 2014, they attended the Texas McCombs School of Business to pursue a degree in Commercialising New Technology. The specific field of study during this period is not provided.

Links



Teams

This person is not in any teams